About Us

Who We Are

The Endocannabinoid and Metabolic Health Group (EMHG) is an educational consortium dedicated to improving patient care by advancing the science and practice of endocannabinoid and metabolic medical conditions.

Our Mission

To provide the most current and comprehensive education related to the endocannabinoid system and related disease conditions.
To contribute to the advancement of these interrelated fields by providing scientific education and communications to an array of clinicians and patients.
To provide expert services to our global partners striving to bring awareness of the relationship between cannabinoid treatments and ECS-related medical conditions.
To elevate the cannabinoid conversation with scientific education and medical expertise that will empower better decision-making.

Our Experience

Collectively, the EMHG team has served the pharmaceutical, bio-science and wellness markets for over 20 years. We’ve partnered with pharmaceutical companies, creative agencies, patient advocacy groups and consumer healthcare groups to create medical communications strategies focused on the importance of patient education and increasing HCP’s scientific knowledge to better guide decision-making.

We have held positions in medical/scientific affairs, clinical services, account management, corporate training, strategic marketing, product management and field sales. We are experts in building relationships that advance the education and science of emerging clinical therapies in the health and wellness communities.

Who We Are

Our Mission

Our Experience

Contact our team today to find out more about how we can serve you!